| Literature DB >> 27468284 |
Yi Wang1, Yan Wang1, Lu Zhang1, Machao Li1, Lijuan Luo1, Dongxin Liu2, Hua Li1, Xiaolong Cao3, Shoukui Hu1, Dong Jin1, Jianguo Xu1, Changyun Ye1.
Abstract
The article reported a novel methodology for real-time PCR analysis of nucleic acids, termed endonuclease restriction-mediated real-time polymerase chain reaction (ET-PCR). Just like PCR, ET-PCR only required one pair of primers. A short sequence, which was recognized by restriction enzyme BstUI, was attached to the 5' end of the forward (F) or reverse (R) PCR primer, and the new F or R primer was named EF or ER. EF/ER was labeled at the 5' end with a reporter dye and in the middle with a quenching dye. BstUI cleaves the newly synthesized double-stranded terminal sequences (5' end recognition sequences and their complementary sequences) during the extension phase, which separates the reporter molecule from the quenching dye, leading to a gain of fluorescence signal. This process is repeated in each amplification cycle and unaffected the exponential synthesis of the PCR amplification. ET-PCR allowed real-time analysis of single or multiple targets in a single vessel, and provided the reproducible quantitation of nucleic acids. The analytical sensitivity and specificity of ET-PCR were successfully evaluated, detecting down to 250 fg of genomic DNA per tube of target pathogen DNA examined, and the positive results were generated in a relatively short period. Moreover, the practical application of ET-PCR for simultaneous detection of multiple target pathogens was also demonstrated in artificially contaminated blood samples. In conclusion, due to the technique's simplicity of design, reproducible data and low contamination risk, ET-PCR assay is an appealing alternative to conventional approaches currently used for real-time nucleic acid analysis.Entities:
Keywords: ET-PCR; LoD; PCR; nucleic acid detection; real time PCR
Year: 2016 PMID: 27468284 PMCID: PMC4942466 DOI: 10.3389/fmicb.2016.01104
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Primers used in this study.
| Primer namea | Sequences and modifications | Length | Genes |
|---|---|---|---|
| S.p-F | 5′-TTCTGCAGAGCGTCCTTTGGTCT-3′ | 23 nt | |
| S.p-R | 5′-CACTCTTACTCGTGGTTTCCAACTTG-3′ | 26 nt | |
| S.p-EF | 5′-Hex-TCGCG-TTCT(BHQ1)GCAGAGCGTCCTTTGGTCT-3′ | 28 mer | |
| S.a-F | 5′-TGTACAAAGGTCAACCAATGACA-3′ | 23 nt | |
| S.a-R | 5′-CAGGACCATATTTCTCTACACCT-3′ | 23 nt | |
| S.a-EF | 5′-Cy5-TCGCG-TGT(BHQ2)ACAAAGGTCAACCAATGACA-3′ | 28 mer | |
| E.f-F | 5′-GCCACTATTTCTCGGACAGC-3′ | 20 nt | |
| E.f-R | 5′-GCTCTGCACCGATTGGACGA-3′ | 20 nt | |
| E.f-EF | 5′-FAM-TCGCG-GCCACT(BHQ1)ATTTCTCGGACAGC-3′ | 25 mer |
Bacterial strains used in this study.
| Bacteria | Serovar/species | Strain number (source of strain)a | Number of strains |
|---|---|---|---|
| 19A | ATCC700674 | 1 | |
| 14 | ATCC6314 | 1 | |
| 19F | ATCC49619 | 1 | |
| 35B | ATCCBAA660 | 1 | |
| 23F | ATCC700669 | 1 | |
| 6A | ATCCBAA659 | 1 | |
| 6B | ATCCBAA658 | 1 | |
| 1 | NCTC7465 | 1 | |
| 5 | ICDC-SP112007 | 1 | |
| 23A | ICDC-SP028 | 1 | |
| 6C | ICDC-SP0261 | 1 | |
| 3 | ICDC-SP31003 | 1 | |
| 18C | ICDC-SPM241 | 1 | |
| 9V | ICDC-SP0269 | 1 | |
| 9N | ICDC-SP0282 | 1 | |
| 15B | ICDC-SP0277 | 1 | |
| U | Isolated strains (ICDC) | 28 | |
| U | ICDC-NPSau001 | 1 | |
| U | ICDC-NPSau002 | 1 | |
| U | ICDC-NPSau003 | 1 | |
| U | ICDC-NPSau004 | 1 | |
| U | ICDC-NPSau005 | 1 | |
| U | Isolated strains (ICDC) | 20 | |
| U | ATCC51299 | 1 | |
| U | ATCC35667 | 1 | |
| U | Isolated strains (ICDC) | 20 | |
| U | Isolated strains (ICDC) | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | EDL933 | 1 | |
| U | ATCC51903 | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | ATCC35667 | 1 | |
| U | ATCC23715 | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| 1d | ICDCNPS001 | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | ATCCBAA340 | 1 | |
| 4a | ATCC19114 | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | ATCC33291 | 1 | |
| U | Isolated strains (ICDC) | 1 | |
| U | Isolated strains (ICDC) | 1 |
The analytical sensitivity for ET-PCR targeting ply, nuc, and Ef0027 genes compared with that of conventional qPCR (SYBR Green) and PCR approaches.
| Assays | Regions recognized | Multiplex detection | LoD for | Fastest time (minutes) | LoD time (minutes) |
|---|---|---|---|---|---|
| S-ET-PCR | 2 | - | 2.5 × 102/2.5 × 102/2.5 × 102 | 21 | 49 |
| M-ET-PCR | 2 | + | 2.5 × 102/2.5 × 102/2.5 × 102 | 24 | 55 |
| qPCR | 2 | - | 2.5 × 102/2.5 × 102/2.5 × 102 | 20 | 49 |
| PCR | 2 | - | 2.5 × 104/2.5 × 104/2.5 × 104 | 150 | 150 |
Comparison of ET-PCR, qPCR (SYBR) and PCR assays for detection of S. pneumonia, S. aureus, and E. faeclis in artificially contaminated blood samples.
| Detection methodsa | Multiplex detection | LoD (no./reaction) | ||
|---|---|---|---|---|
| M-ET-PCR | + | 13 CFU ~ (650 CFU/ml) | 13.6 CFU ~ (680 CFU/ml) | 14.2 CFU ~ (710 CFU/ml) |
| qPCR | - | 13 CFU ~ (650 CFU/ml) | 13.6 CFU ~ (680 CFU/ml) | 14.2 CFU ~ (710 CFU/ml) |
| PCR | - | 130 CFU ~ (6500 CFU/ml) | 136 CFU ~ (6800 CFU/ml) | 142 CFU ~ (7100 CFU/ml) |